Protagonist Therapeutics
PTGX
#2241
Rank
โ‚ฌ7.56 B
Marketcap
115,88ย โ‚ฌ
Share price
2.00%
Change (1 day)
59.03%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): 1,10ย โ‚ฌ

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is 1,11ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,87ย โ‚ฌ a decrease over its 2024 EPS that were of 4,08ย โ‚ฌ.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,10ย โ‚ฌ-158.9%
2025-1,87ย โ‚ฌ-145.76%
20244,08ย โ‚ฌ-402.7%
2023-1,35ย โ‚ฌ-43.08%
2022-2,37ย โ‚ฌ-3.7%
2021-2,46ย โ‚ฌ35%
2020-1,82ย โ‚ฌ-33.33%
2019-2,73ย โ‚ฌ74.42%
2018-1,57ย โ‚ฌ-20.74%
2017-1,98ย โ‚ฌ-45.64%
2016-3,64ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA